ADAGIO THERAPEUTICS INC's ticker is and the CUSIP is 00534A102. A total of 71 filers reported holding ADAGIO THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.2%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 9,248,250 | $10,173,075 | 13.19% |
| Deep Track Capital, LP | 10,953,937 | $12,049,331 | 0.36% |
| 683 Capital Management, LLC | 3,625,000 | $3,987,501 | 0.30% |
| MAVERICK CAPITAL LTD | 11,765,787 | $12,942,366 | 0.24% |
| Bain Capital Life Sciences Investors, LLC | 1,799,595 | $1,979,555 | 0.22% |
| Redmile Group, LLC | 3,065,714 | $3,372,285 | 0.20% |
| Slate Path Capital LP | 3,735,000 | $4,108,500 | 0.08% |
| Orbimed Advisors | 2,425,800 | $2,668,380 | 0.05% |
| DIMENSION CAPITAL MANAGEMENT LLC | 189,871 | $208,858 | 0.04% |
| TOMS Capital Investment Management LP | 698,500 | $768,350 | 0.03% |